vanthana bharathi
@drvanthanab
@mdandersonnews Leukemia Fellow
ID: 135097610
https://www.instagram.com/drvanb/ 20-04-2010 09:50:15
209 Tweet
97 Takipçi
314 Takip Edilen
Five years ago, I chose Memorial Sloan Kettering Cancer Center in New York for lifesaving care from a team of oncologists and surgeons. In 2022, I was honoured to cut the ribbon with distinguished guests at MSK’s India centre in Chennai. Today, MSK serves India via a remote #secondopinion program, and
Tomorrow at Endocrine Society #endo2024 stop by poster 381. Hyperparathyroidism due to an uncommon etiology, and unique clinical features. | Houston Methodist
📝 A study presented at #SOHO2024 investigated the therapeutic benefit associated with immune checkpoint inhibitors for the treatment of #MDS. 📰 Read more about the study by vanthana bharathi of Saint Peter's HCS. ➡️ buff.ly/3z9Q2Xw
Amazing poster on the results of the Phase Ib/II study of CPX-351 plus #Venetoclax for R/R #AML, presented by vanthana bharathi. Come by poster 4272 in the poster hall starting at 5:30 pm ASH MD Anderson Cancer Center #EndCancer #Leukemia #ASH24 #SanDiego #GaslampQuarter
It was lovely speaking with vanthana bharathi of MD Anderson Cancer Center at #ASH24 to hear the results of a Phase Ib/II study of CPX-351 plus venetoclax in patients with R/R AML. Watch here: 👉 ow.ly/Y7fX50UGK03 👈 #AMLsm #Leusm #Leukemia #CTSM #TrialUpdate #HemOnc ASH
Spot on editorial by Nico Gagelmann and Nicolaus Kröger on the role of TP53 in #MPN, reflecting upon a recent important study in AmericanJournalofHematology doi.org/10.1002/ajh.27… #hempath #molpath
The present and future of medical management of Obesity by Andrés Calderón V. Houston Methodist A Must-read! #obesity #cardiovasculardisease Medical Management of Obesity: Current Trends and Future Perspectives | Methodist DeBakey Cardiovascular J journal.houstonmethodist.org/articles/10.14…
🚨Thrilled to share our latest work: “Tumor-Infiltrating Clonal Hematopoiesis” NEJM - we investigated how age-related blood mutations impact cancer when they infiltrate tumors, with Elsa Bernard Maria Zagorulya, Elli Papaemmanuil, PhD Charles Swanton + more nejm.org/doi/full/10.10…
Long awaited results of #VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results for OS. We unfortunately remain in the dreaded boulevard of broken dreams in higher risk #MDSsm. Subgroup analyses will be important. news.abbvie.com/2025-06-16-Abb…
👉Leukemia team together MD Anderson Cancer Center today! Naveen Pemmaraju, MD Wei Ying Jen Tapan Kadia vanthana bharathi Roberta Azevedo 🙌